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Notch receptors and their ligands play important roles in both normal animal development and pathogen-
esis. We show here that the F-box/WD40 repeat protein SEL-10 negatively regulates Notch receptor activity by
targeting the intracellular domain of Notch receptors for ubiquitin-mediated protein degradation. Blocking of
endogenous SEL-10 activity was done by expression of a dominant-negative form containing only the WD40
repeats. In the case of Notch1, this block leads to an increase in Notch signaling stimulated by either an
activated form of the Notch1 receptor or Jagged1-induced signaling through Notch1. Expression of dominant-
negative SEL-10 leads to stabilization of the intracellular domain of Notch1. The Notch4 intracellular domain
bound to SEL-10, but its activity was not increased as a result of dominant-negative SEL-10 expression. SEL-10
bound Notch4 via the WD40 repeats and bound preferentially to a phosphorylated form of Notch4 in cells. We
mapped the region of Notch4 essential for SEL-10 binding to the C-terminal region downstream of the ankyrin
repeats. When this C-terminal fragment of Notch4 was expressed in cells, it was highly labile but could be
stabilized by the expression of dominant-negative SEL-10. Ubiquitination of Notch1 and Notch4 intracellular
domains in vitro was dependent on SEL-10. Although SEL-10 interacts with the intracellular domains of both
Notch1 and Notch4, these proteins respond differently to interference with SEL-10 function. Thus, SEL-10
functions to promote the ubiquitination of Notch proteins; however, the fates of these proteins may differ.
Notch/LIN-12 receptors regulate cell fate decisions during
normal animal development and pathogenesis. For example, in
Caenorhabditis elegans, LIN-12 ensures that only one of two
undifferentiated gonadal cells develops into an anchor cell,
while the other cell becomes a ventral uterine precursor cell
(8). Notch genes have been linked to several human patholog-
ical conditions, including cancer (21), vascular failure (13), and
schizophrenia (41).
The Notch/LIN-12 signaling pathway is activated when a
ligand-receptor interaction induces a proteolytic cleavage
event that releases the intracellular domain of the receptor
from the cell membrane (25, 32, 35). Release of the intracel-
lular domain of Notch is dependent on presenilins (5, 35).
Mammalian Notch ligands are membrane-tethered proteins
referred to as Jagged and Delta-like. The signaling module of
a Notch/LIN-12 receptor is the intracellular domain that trans-
locates to the nucleus to modulate gene expression (11, 34).
The nuclear activity of Notch/LIN-12 receptors relies on the
interaction between the intracellular domain of a Notch/
LIN-12 receptor and the transcription factor suppressor of
hairless (Su[H]) in Drosophila, Lag-1 in C. elegans (9, 37, 42),
or CBF-1 or RBP-J in mammals (7, 11). The complex of
Su(H) and the Notch/LIN-12 intracellular domain is a tran-
scriptional activator and induces genes with a regulatory se-
quence recognized by the Su(H) DNA binding domain.
Less is known about the subsequent down-regulation of
Notch signaling. Insight into this aspect of Notch signaling
came from identification of the C. elegans gene sel-10, which
was first identified in a genetic screen as a negative regulator of
the Notch/LIN-12 signaling pathway (36). SEL-10 is related to
the budding yeast protein CDC4 (10). Members of the CDC4
family are characterized by an F-box domain (43) and seven
WD40 repeats, both protein-protein interaction motifs. In pre-
vious studies, CDC4 family proteins have been shown to me-
diate target protein ubiquitination and degradation. Specifi-
cally, the WD40 repeats bind to the target protein in a
phosphorylation-dependent manner, while the F-box domain
tethers the protein to the SCF ubiquitin ligase complex via
binding to the SKP1 adapter (4, 6, 16, 33). C. elegans sel-10 was
shown to functionally reduce lin-12 activity, and coimmuno-
precipitation studies demonstrated that C. elegans SEL-10 pro-
tein can associate with LIN-12 or murine Notch4 protein (10).
Based on this precedent, we have proposed that SEL-10 is a
conserved F-box/WD40 repeat protein that negatively regu-
lates Notch/LIN-12 signaling by targeting the intracellular do-
main of Notch/LIN-12 receptors for ubiquitin-mediated pro-
tein degradation (10).
To elucidate the mechanism by which SEL-10 regulates
Notch/LIN-12 signaling, we analyzed the function of a human
homologue of C. elegans sel-10 in mammalian cells. We dem-
onstrate that human SEL-10 (hSEL-10) binds mammalian
Notch proteins in a domain-specific manner. We also show that
Notch proteins are phosphorylated and that the interaction
between SEL-10 and Notch proteins is phosphorylation depen-
dent. Through an in vitro ubiquitination assay, we show that
SEL-10 can mediate Notch protein ubiquitination and that
Notch proteins are degraded by the 26S proteasome in the cell.
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The proposed role of SEL-10 in Notch ubiquitination and
degradation is further supported by data showing that a
SEL-10 deletion mutant containing only the WD40 repeats can
stabilize Notch proteins by competing with wild-type SEL-10
for binding to Notch. In principle, Notch down-regulation by
SEL-10 may be physiologically important for sensitizing cells to
incoming signals from Notch ligands; alternatively, SEL-10
may provide a general mechanism for preventing excess Notch
signaling.
MATERIALS AND METHODS
Cell lines and media. Bosc23 cells (26) were maintained in Dulbecco’s mod-
ified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum and
penicillin-streptomycin. Sf9 insect cells were maintained in Gibco BRL SF900II
medium. Hi5 insect cells were maintained in Ex-Cell 400 medium (JRH Bio-
sciences). Bacterial strain DH10Bac was purchased from Gibco BRL.
Plasmids and vectors. The following plasmids were constructed by use of
pQNCXII (14), a retrovirus vector that drives gene expression under the control
of a cytomegalovirus (CMV) promoter. pQNClacZ contains the bacterial lacZ
gene. pQNCint-3HAHis expresses the entire Int-3 protein (amino acids 1412 to
1964 of the mouse Notch4 protein), whose C terminus is fused to hemagglutinin
(HA) and six-His tags. pQNCint-3CHAHis expresses a C-terminal fragment of
the mouse Notch4 protein (amino acids 1789 to 1964) with HA and six-His tags
at the end. pQNCNotch1ICHAHis expresses the rat Notch1 intracellular domain
(amino acids 1747 to 2531) with HA and six-His tags at its C terminus.
The following plasmids were constructed by use of pLNCX (24), a retrovirus
vector that drives gene expression under the control of a CMV promoter. These
plasmids express different regions of the Int-3 protein and have been described
previously (40). pLNCint-3HA contains cDNA corresponding to the Notch4
region expressed in the Int-3 insertion, beginning at amino acid 1411; the
Notch4(int-3) protein includes the entire intracellular domain of Notch4 and
additional sequences. The entire protein is HA tagged at the C terminus.
pLNCint-3NHA expresses an Int-3 protein lacking the region upstream of the
CDC10/ankyrin repeats. pLNCint-3CHA expresses an Int-3 protein lacking the
region distal to the CDC10/ankyrin repeats. pLNCint-3NCHA expresses the
CDC10/ankyrin repeat region of Int-3. pLNCint-3CDCHA expresses an Int-3
protein lacking the CDC10/ankyrin repeats. All of the above Int-3 proteins have
an in-frame HA tag at the C terminus. pHyTC-Jagged1 is described elsewhere
(38) and drives the expression of full-length Jagged1 from the CMV promoter.
The following plasmids were constructed by use of pCS2-MT6 (30), a vector
that drives gene expression under the control of a CMV promoter. There are six
myc tags upstream of the polyclonal sites. pCS2hSEL-10myc expresses full-length
hSEL-10 protein with six myc epitope tags at the N terminus. pCS2hSEL-
10WDmyc expresses the WD40 repeat region (amino acids 184 to 540) of
hSEL-10 with six myc epitope tags at the N terminus. pCS2hSEL-10Fmyc ex-
presses the F-box region (amino acids 1 to 207) of hSEL-10 with six myc epitope
tags at the N terminus.
Plasmid pCS2HA-HsSKP1, which expresses HA-tagged full-length human
SKP1, was obtained from Mike Tyers, Mt. Sinai Hospital, Toronto, Canada.
The following plasmids were constructed by use of pFastBac (Gibco BRL), a
shuttle vector for making baculoviruses overexpressing proteins in insect cells.
pFastBacInt-3HA encodes the entire mouse Notch4(int-3) sequence fused at its
C terminus to an HA tag. pFastBacInt-3CHAHis encodes the C-terminal region
(amino acids 1789 to 1964) of mouse Notch4(int-3) fused at its C terminus to HA
and six-His tags. pFastBacN1ICHAHis encodes the intracellular domain (amino
acids 1747 to 2531) of rat Notch1 fused at its C terminus to HA and six-His tags.
pFastBachSEL-10myc expresses full-length hSEL-10 with six N-terminal myc
epitope tags. pFastBachSEL-10WDmyc expresses the WD40 repeat region (ami-
no acids 184 to 540) of hSEL-10 with six N-terminal myc tags.
Luciferase reporter assays. Transient transfections were performed by calcium
phosphate precipitation. For assessment of activated Notch signaling, HeLa cells
(1.2  105) plated 1 day earlier in six-well plates were transfected in triplicate
with 50 ng of pQNCN1ICHA or 50 ng of pLNCX in combination with 670 ng of
luciferase vector (pGA981-6) (15) and 160 ng of pLNClacZ (control for trans-
fection efficiency) and with or without 500 ng of pCS2hSEL-10WDmyc. To
determine ligand-induced Notch signaling, coculture assays were performed us-
ing HeLa and Bosc23 cells. HeLa cells (1.2  106) plated 1 day earlier in 10-cm
plates were transfected with 7.5 g of pBOS Notch1 (20), 4 g of pGA981-6, and
1 g of pLNClacZ and with or without 1.5 g of pCS2hSEL-10WDmyc. Bosc23
cells (3  106) plated 1 day earlier in 10-cm plates were transfected with either
25 g of pHyTCJagged1 (38) or 25 g of pLNCX. One day after transfection, the
HeLa and Bosc23 cells were cocultured in triplicate (1:1) on six-well plates for
24 h. Luciferase activity was determined 2 days posttransfection using an en-
hanced luciferase assay kit (BD PharMingen), and -galactosidase activity was
determined using a Galacto-Light Plus kit (PE Biosystems) and a Berthold
dual-injection luminometer.
Transfection, immunoprecipitation, and Western blot analysis. For transient
transfection, a confluent plate of Bosc23 cells was split 1:3 on the day prior to
transfection. For each 60-mm plate of cells, 4 g of each plasmid DNA was
transfected using the calcium phosphate precipitation method. The total amount
of DNA was kept constant by supplementation with lacZ-containing plasmids.
Two days after transfection, cells were harvested and lysed in TENT buffer (50
mM Tris-Cl [pH 8.0], 2 mM EDTA, 150 mM NaCl, 1% Triton X-100) containing
protease inhibitors (2 g of aprotinin/ml, 2 g of leupeptin/ml, 2 g of pepstatin/
ml, 0.5 mM phenylmethylsulfonyl fluoride [PMSF]). Lysates were clarified by
centrifugation at 10,000  g for 10 min, and protein content was determined
using a Bio-Rad protein assay kit. Equal amounts of extracts from samples were
precleared with Sepharose CL-4B beads, incubated with antibodies (50 l of
12CA5 anti-HA supernatant, 200 l of 9E10 anti-myc supernatant, or 2 l of
anti-FLAG antibody) for 2 h at 4°C, and then incubated with 40 l of a 50%
slurry of protein A-Sepharose for 1 h at 4°C. The protein A-Sepharose beads
were washed with TENT buffer three times by vortexing for 5 min each time. The
beads were boiled in 30 l of protein gel loading buffer (50 mM Tris-Cl [pH 6.8],
100 mM dithiothreitol, 2% [wt/vol] sodium dodecyl sulfate [SDS], 0.1% brom-
phenol blue, 10% [wt/vol] glycerol), electrophoresed on an SDS-polyacrylamide
gel, and transferred to a polyvinylidene difluoride membrane.
A Western blot was blocked overnight at 4°C with TBST (10 mM Tris [pH 8.0],
150 mM NaCl, 0.2% Tween 20) containing 1% bovine serum albumin (BSA).
The blot was then incubated with primary antibody diluted (1:50 for 12CA5; 1:10
for 9E10; 1:2,000 for anti-FLAG) in TBST-BSA for 1 h, washed three times for
5 min each time with TBST, and incubated with secondary antibody (anti-mouse
immunoglobulin–horseradish peroxidase, 1:10,000; Amersham) in TBST-BSA
for 1 h. After three washes, the signal was visualized by chemiluminescence
(Amersham ECL kit).
12CA5 anti-HA antibody was obtained from BabCo., Richmond, Calif. 9E10
anti-myc antibody was prepared from culture supernatants of the 9E10 hybrid-
oma (18). Anti-FLAG antibody was purchased from Sigma.
Dephosphorylation of proteins with CIP. Immunoprecipitation was carried
out to obtain the protein to be treated with calf intestinal phosphatase (CIP). At
the end of the immunoprecipitation, the protein A-Sepharose beads were thor-
oughly washed with TENT buffer, and the solution was completely removed by
aspiration. The beads were then suspended in 30 l of buffer containing 2 l of
CIP (New England Biolabs) and incubated at 37°C for 2 h. Ten microliters of 4
protein gel loading buffer was added to the reaction mixture. The sample was
boiled, loaded onto an SDS-polyacrylamide gel, and subjected to Western blot
analysis.
Pulse-chase labeling assay. Bosc23 cells were transfected with plasmid DNA
as described above. Two days after transfection, the cells were washed and
incubated in DMEM lacking methionine (Met) and cysteine (Cys) for 0.5 h to
deplete Met and Cys. Cells were then incubated for 0.5 h in labeling DMEM,
containing 35S-labeled Met and Cys at 0.5 mCi/ml. The labeling medium was
then replaced with regular DMEM. Cells were harvested every 0.5 h during the
chase period for up to 2.5 h. Lactacystin (10 M) was added to both pulse-
labeling and pulse-chase media.
The harvested cells were lysed and immunoprecipitated as described above.
The precipitates were separated on an SDS-polyacrylamide gel. The gel was fixed
for 30 min in isopropanol-water-acetic acid (25:65:10), stained for 30 min with
Amplify (Amersham), vacuum dried, and exposed to X-ray film to visualize and
quantitate the signal.
Generation of baculovirues and in vitro ubiquitination assays. Baculoviruses
used in the in vitro ubiquitination assays were generated with the Gibco BRL
FastBac system by following the manufacurer’s protocols. Hi5 insect cell lysates
were prepared 48 h postinfection from cells coinfected with baculoviruses that
expressed SEL-10myc or SEL-10WDmyc plus hCUL1, hSKP1, and hHRT1. Cell
lysis was achieved by incubating cells in buffer containing 20 mM HEPES (pH
7.4), 150 mM NaCl, 50 mM NaF, 60 mM -glycerophosphate, 0.3% Triton X-100
100 M N-acetyl-Leu-Leu-norleucinal (LLnL), and protease inhibitor cocktail
(Sigma). Crude Hi5 cell lysates (500 g) were incubated with 10 l of anti-myc
beads for 2 h at 4°C to allow binding of myc-tagged SEL-10 subunits. Beads were
washed three times with lysis buffer and incubated with 500 g of crude lysates
prepared from Hi5 cells infected with baculoviruses that expressed either
Notch4(int-3)HA, Notch4(int-3)CHAHis6, or N1ICHAHis6 to allow substrate
binding to SCF. Beads were washed three times with lysis buffer, washed two
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times with 20 mM HEPES (pH 7.4)–100 mM potassium acetate–1 mM dithio-
threitol, and incubated with the following ubiquitination reaction components:
50 ng of His6yUBA1, 500 ng of hCDC34, 1 l of 10 ATP-regenerating system,
1 l of 10 reaction buffer (6), and 5 g of either ubiquitin or methylubiquitin
(Boston Biochem). Ubiquitination reactions were carried out for 60 min at 30°C
and terminated by the addition of protein gel loading buffer. The samples were
fractionated by SDS-polyacrylamide gel electrophoresis (PAGE), and Notch
proteins were visualized by Western blotting with anti-HA antibodies.
RESULTS
hSEL-10 is an F-box/WD40 protein that inhibits Notch sig-
naling. Figure 1A presents a schematic of the identified do-
mains of the hSEL-10 protein. The full coding sequence for
human SEL-10 translates into a 540-amino-acid protein (Gen-
Bank accession no. AY008274). Like its homologue in C. el-
egans, hSEL-10 contains an N-terminal F-box domain followed
by seven WD40 repeats. The predicted protein sequences of C.
elegans Sel-10 and hSEL-10 show 47.6% identity and approx-
imately 57% similarity. Higher conservation is observed in the
WD40 repeats (60% identity) than in the N terminus and
F-box domains (30 and 35% identities, respectively). The hu-
man Sel-10 gene reported here is similar to FLJ117071 of the
New Energy and Industrial Development Organization
(NEDO) human cDNA sequencing project and is also referred
to as FBXW6.
To explore the activity and binding potential of hSEL-10, the
coding sequence for six consecutive myc epitope tags was
added to the 5 end of SEL-10 (Fig. 1B). We also generated
two variants of SEL-10; SEL-10Fmyc contains the N terminus
through the F-box and terminates just prior to the first WD40
repeat, and SEL-10WDmyc contains the WD40 repeats but
not the F-box or any sequences upstream of the F-box (Fig.
1B). By analogy to mammalian F-box/WD40 repeat family
members, we predict that the F-box mediates association with
the ubiquitination machinery and that the WD40 repeats pro-
vide a binding domain for substrates.
We were interested in how SEL-10 might interact, both
physically and functionally, with a classic Notch intracellular
domain protein, Notch1IC, and an oncogenic form of the
Notch4 protein. We used a variant of the Notch4 protein,
originally referred to as int-3, and we refer to this variant as
Notch4(int-3) (39). It contains a short region of the extracel-
lular sequence, the transmembrane domain, and the intracel-
lular domain of mouse Notch4 (see Fig. 3) but does not contain
a signal sequence. Notch4(int-3) behaves as a gain-of-function
mutant of Notch4 (12, 38, 40) and promotes mammary tumor-
igenesis in mice.
Engineered versions of F-box/WD40 proteins, such as
-TRCP, which regulates -catenin stability, that contain only
the WD40 repeats function as dominant-negative proteins (17,
19, 46). We asked whether a variant of SEL-10 containing only
the WD40 repeats (SEL-10WDmyc; Fig. 1B) could inhibit
endogenous SEL-10 function. Using an in vitro culture system,
we examined how the overexpression of SEL-10WDmyc influ-
ences Notch receptor signaling. Receptor activation was as-
sessed with a luciferase reporter assay that responds to the
transcriptional activation of a downstream Notch signaling
component, RBP-J. The expression of an activated Notch1
receptor (Notch1IC) in HeLa cells induced reporter expres-
sion greater than 500-fold relative to that in control HeLa cells
FIG. 1. hSEL-10 and its effects on Notch signaling. (A) Compar-
ison of C. elegans SEL-10 and hSEL-10 proteins. Percentages indicate
amino acid identities between homologous domains of the two pro-
teins. (B) Epitope-tagged hSEL-10 proteins used in biochemical stud-
ies. Six myc epitope tags (6Xmyc) were engineered to fuse in frame to
three SEL-10 variants at their N termini. (C and D) A SEL-10 variant
expressing only the WD40 repeats upregulates signaling of activated
Notch1 (C) and Jagged1-induced signaling of full-length Notch1 (D).
Notch signaling was assessed by a luciferase assay using a reporter
construct containing the RBP-J binding sites. In panel C, an activated
Notch1 construct (Notch1IC) and the reporter construct were trans-
fected with or without SEL-10WDmyc into HeLa cells. Reporter gene
transactivation was measured 2 days posttransfection, and the fold
induction of luciferase activity was calculated relative to that in HeLa
cells that were transfected with an empty vector (pLNCX) and the
reporter construct. In panel D, Jagged1 or pLNCX (control) was
transiently expressed in Bosc23 cells. These cells were cocultured with
HeLa cells transiently expressing the full-length Notch 1 receptor,
luciferase reporter, and SEL-10WDmyc. Luciferase activity was mea-
sured 1 day after coculturing. Each bar represents the mean from
experiments done in triplicate. Error bars represent standard devia-
tions.
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transfected with the reporter and an empty vector (Fig. 1C).
Coexpression of the SEL-10WDmyc construct with activated
Notch1 increased reporter expression by approximately two-
fold (Fig. 1C), indicative of enhanced Notch signaling.
Notch4(int-3) expression induced reporter expression greater
than 400-fold; however, coexpression of the SEL-10WDmyc
construct with Notch4(int-3) only minimally increased reporter
activity (data not shown). Thus, Notch1- and Notch4-induced
signaling responded differently to interference with endoge-
nous SEL-10 function. We also overexpressed full-length
SEL-10 with Notch proteins and did not find a significant effect
on signaling via either Notch1IC or Notch4(int-3) (data not
shown), suggesting that sufficient SEL-10 activity is present
within cells to mediate its activity.
We determined whether the SEL-10WDmyc construct could
augment ligand-induced activation of Notch1 signaling. For
these experiments, we used a coculture reporter assay with one
cell type expressing the Notch ligand, Jagged1, and another cell
type expressing full-length Notch1 and a reporter. Bosc23 cells
(a derivative of human HEK 293 cells) expressing either
Jagged1 or an empty vector were cocultured with HeLa cells
expressing full-length Notch1, the reporter, and SEL-10WD-
myc (Fig. 1D). We observed approximately a fourfold induc-
tion in reporter activation in cocultures of cells expressing
Jagged1 and Notch1 relative to that in cocultures in which
Notch1 was expressed without exogenous Jagged1. In cocul-
tures of cells expressing Jagged1 with cells expressing both
Notch1 and SEL-10WDmyc, a further 2.5-fold increase in re-
porter induction was observed. These results demonstrate that
with activated Notch1 signaling and with Jagged1-induced
Notch1 signaling, expression of the SEL-10WDmyc protein
enhanced Notch signaling. Thus, the truncated SEL-10 protein
acts in a dominant-negative manner, potentially by competing
with endogenous SEL-10 for binding to Notch. We postulate
that the augmented Notch1 signaling that we observed is due
to a blockade of SEL-10-mediated degradation of the Notch1
protein.
SEL-10 binds Notch through the WD40 domain and SKP1
through the F-box domain. To investigate whether hSEL-10 is
involved in Notch protein ubiquitination and degradation, we
first studied the physical interaction between hSEL-10 and
mouse Notch4 proteins using coimmunoprecipitation assays.
Previous reports suggested that detecting F-box/WD40-target
protein interactions is difficult due to the extreme lability of the
target protein after ubiquitination. In initial studies we found
that hSEL-10 binding to the oncogenic Notch4(int-3) variant
could be detected, and we thus focused our analysis on defining
this interaction in detail. Binding assays were conducted after
coexpression of the myc-tagged variants of hSEL-10 and HA-
tagged Notch4(int-3) (40). Bosc23 cells were used for transient
transfections with various expression constructs. Cell extracts
were prepared and immunoprecipitated with either anti-HA or
anti-myc antibodies. Western blotting of the immunoprecipi-
tates demonstrated that Notch4(int-3)HA (Fig. 2A, bottom
panel) and all three SEL-10 variants (Fig. 2A, second panel
from the top) were recovered at comparable levels. By probing
the anti-myc immunoprecipitates with anti-HA antibody, we
demonstrated that Notch4(int-3)HA associated with either
full-length hSEL-10 (Fig. 2A, top panel, lane 6) or the WD40
domain (Fig. 2A, top panel, lane 8) but not with the F-box
domain (Fig. 2A, top panel, lane 7). We confirmed the inter-
action between Notch4(int-3) and SEL-10 proteins by immu-
noprecipitating Notch4(int-3)HA with anti-HA antibody and
then probing for myc-tagged SEL-10 proteins. As shown in Fig.
2A (third panel from the top), full-length hSEL-10 (lane 6) but
not the F-box domain (lane 7) complexes with Notch4(int-
3)HA; SEL-10WDmyc (lane 8) comigrated with the heavy
chain of immunoglobulin and therefore could not be visualized
in this experiment. In conclusion, hSEL-10 physically associ-
ates with mouse Notch4(int-3) through the WD40 domain,
whereas the F-box domain is not required for this interaction.
Based on previous studies of F-box/WD40 proteins, we pre-
dict that the F-box domain of SEL-10 should interact with
other components of the ubiquitination machinery, such as
SKP1. We tested this possibility with coimmunoprecipitation
assays using HA-tagged full-length human SKP1 and myc-
tagged SEL-10 proteins. As shown in Fig. 2B (top panel, lanes
6, 7, and 8), SKP1HA interacted with full-length hSEL-10 and
the F-box domain but not with the WD40 domain. Consistent
with this observation, we were able to detect full-length
SEL-10 and the F-box domain in the immunoprecipitates of
SKP1 (Fig. 2B, third panel from the top, lanes 6 and 7). This
observed interaction implies that SEL-10, like other F-box/
WD40 family proteins, is part of an E3 ubiquitin ligase that
mediates the ubiquitination and degradation of target proteins.
The Notch4 C-terminal domain binds to hSEL-10. To map
the domains of Notch4(int-3) that are required for the physical
interaction between Notch4 and SEL-10, we tested a series of
Notch4(int-3) deletion variants (schematized in Fig. 3A) for
their ability to complex with full-length hSEL-10. We chose the
Notch4(int-3) proteins to map domains of interaction because
of the ease of detection of Notch–SEL-10 complexes.
Coexpression of myc-tagged SEL-10 and HA-tagged Notch4
(int-3) variants was monitored by immunoprecipitation of
SEL-10 with anti-myc antibody; the immunoprecipitates were
then probed with anti-HA antibody. This coimmunoprecipita-
tion assay revealed that N4(int-3), N4(int3)N, and N4(int-
3)CDC proteins interacted with SEL-10 (Fig. 3B, top panel,
lanes 8, 9, and 12). When the coimmunoprecipitation was
conducted in a complementary fashion by immunoprecipi-
tating with anti-HA antibody for Notch4 proteins and then
probing with anti-myc antibody for SEL-10, we detected
SEL-10 in the immune complexes of N4(int-3) and N4(int-
3)N (Fig. 3B, third panel from the top, lanes 8 and 9). All
three of the Notch4(int-3) variants that interact with SEL-10
contain the C-terminal domain, and removal of this domain
abolishes the interaction between Notch4(int-3) and SEL-
10. These results suggest that the C-terminal domain of
Notch4(int-3), distal to the CDC10/ankyrin repeats, binds
SEL-10.
We found that the C-terminal domain of Notch4(int-3)
alone was sufficient to bind SEL-10 in coimmunoprecipitation
assays using full-length hSEL-10 and a Notch4(int-3) fragment
containing only the C-terminal domain, N4(int-3)C. N4(int-3)C
could be detected after expression in Bosc23 cells (Fig. 3C,
middle panel, lanes 2, 4, 6, and 8). However, when coimmu-
noprecipitations were carried out under standard conditions,
as described above, we failed to detect a complex between
Notch4(int-3)C and hSEL-10. To prevent ubiquitin-mediated
turnover, we treated cells with a specific proteasome inhibitor,
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lactacystin, before harvest. After lactacystin treatment, we de-
tected N4(int-3)C proteins in the immunoprecipitates of hSEL-10
(Fig. 3C, top panel, lane 8). Thus, under normal conditions, the
interaction between N4(int-3)C and hSEL-10 is probably tran-
sient and difficult to detect due to proteasome-dependent turn-
over of SEL-10-bound Notch4(int-3)C.
SEL-10 binds to phosphorylated forms of Notch4(int-3) pro-
teins. Upon Western blot analysis of Notch4(int-3) variants, we
noted that some of the Notch4(int-3) proteins appeared as
multiple bands (Fig. 3B, bottom panel, lanes 9 and 12), which
might represent Notch protein modification by phosphoryla-
tion. To address this question, we determined if the pattern of
FIG. 2. hSEL-10 interacts with Notch through the WD40 repeats and SKP1 through the F-box. (A) Physical interactions between hSEL-10 and
mouse Notch4. HA-tagged Notch4(int-3) protein was coexpressed with three six-myc-epitope-tagged SEL-10 variants in Bosc23 cells by transient
transfection. Immunoprecipitation (IP) and Western blotting were performed using either anti-HA or anti-myc antibody to demonstrate that the
proteins are well expressed and properly immunoprecipitated (second panel from the top and bottom panel). Anti-HA antibody was then used to
probe the anti-myc antibody immunoprecipitates to reveal Notch4(int-3)HA protein in immune complexes of either SEL-10myc or SEL-10WDmyc
(top panel). Similarly, anti-myc antibody was used to probe anti-HA antibody immunoprecipitates to reveal SEL-10 proteins associated with
Notch4(int-3)HA (third panel from the top). (B) Physical interactions between hSEL-10 and human SKP1. HA-tagged SKP1 was coexpressed with
three SEL-10 variants in Bosc23 cells. Immunoprecipitation followed by Western blotting using anti-HA or anti-myc antibody shows that the
proteins are well expressed and precipitated efficiently (second panel from the top and bottom panel). Anti-myc antibody immunoprecipitates were
probed with anti-HA antibody (top panel) to reveal SKP1HA associated with SEL-10 proteins, and anti-myc antibody was used to detect SEL-10
proteins in immunoprecipitates of SKP1HA (third panel from the top). Arrows indicate the signal of SKP1HA, which comigrates with the light
chain of the antibody.
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migration could be altered by phosphatase treatment of im-
munoprecipitated Notch4(int-3) proteins. We focused on the
N4(int-3)N variant, which contains the CDC10 repeats and
the C-terminal region (Fig. 3A). SEL-10myc and N4(int-3)
NHA were coexpressed in Bosc23 cells. When immune com-
plexes containing N4(int-3)NHA were probed with anti-HA
antibody, three bands, ranging from 48 to 51 kDa, were de-
tected (Fig. 4, lane 1). After treatment with CIP, the top two
bands were significantly diminished, indicating that they had
become dephosphorylated (Fig. 4, lane 2).
We next determined which forms of N4(int-3)N were as-
sociated with SEL-10. The same cell lysate was immunopre-
cipitated with anti-myc antibody to isolate SEL-10myc and
then probed with anti-HA antibody. The slowest migrating
form of N4(int-3)NHA protein was the predominant form
associated with SEL-10 (Fig. 4, lane 3). This immune complex
was treated with CIP, and the slower migrating forms were
diminished at the expense of the faster migrating forms (Fig. 4,
lane 4). This observation suggests that hSEL-10 preferentially
binds to phosphorylated forms of Notch4(int-3) and is consis-
tent with the behavior of CDC4-like proteins, which bind to
phosphorylated target proteins. The bulk population of N4(int-
3)N molecules was efficiently dephosphorylated by CIP,
whereas those bound to SEL-10 were not (Fig. 4, compare
lanes 2 and 4). We speculate that the direct interaction of
SEL-10 with phosphate residues on N4(int-3)N may have
shielded N4(int-3)N from access to CIP. We also noted that
Notch4 variants that contain the C terminus [N4(int-3)N,
N4(int-3)CDC, and N4(int-3)C] typically migrated as several
species. These other Notch4(int-3) variants were also tested in
this assay, and the slower migrating forms of these proteins
were also diminished after phosphatase treatment (data not
shown). On the basis of these results and the results shown
in Fig. 3B and C, we conclude that the C terminus of
Notch4(int-3) is a site of phosphorylation and is the domain
required for the Notch4–SEL-10 interaction.
Proteasome inhibitors and a dominant-negative form of
hSEL-10 stabilize Notch proteins. To study whether Notch
proteins are degraded by the ubiquitin/proteasome pathway,
cells expressing Notch proteins were treated with proteasome
inhibitors. After treatment, Western blot analysis was used to
measure the changes in the steady-state levels of these pro-
teins. A protein containing the C-terminal tail of Notch4(int-3)
was expressed poorly in transfected Bosc23 cells (Fig. 5A,
zero-hour time point), but the levels of this protein were in-
creased after lactacystin treatment (Fig. 5A), indicating turn-
over by the proteasome. Notch4(int-3) proteins were expressed
well in transfected Bosc23 cells (Fig. 2A, bottom panel), and
the levels of these proteins were not significantly increased
after lactacystin treatment (data not shown). Thus, the
Notch4(int-3) protein was not efficiently processed by the pro-
teasome, whereas a fragment containing the C-terminal tail of
Notch4(int-3) was. A protein containing the entire intracellular
domain of murine Notch1, N1CHAHis, was stabilized by treat-
ment with another specific proteasome inhibitor, MG132 (Fig.
5B). Steady-state levels of several intracellular Notch proteins
increased upon treatment with proteasome inhibitors, indicat-
ing that they are targeted for degradation via the proteasome
pathway.
To determine whether the increased steady-state levels of
Notch proteins were due to increased stability, we carried out
pulse-chase analysis to assess the half-life of the N4(int-3)C
protein, the C terminus of N4(int-3). Transfected cells were
pulse-labeled, cell extracts were prepared and immunoprecipi-
tated, and the intensities of immunoprecipitated protein bands
were quantified to compare the relative Notch protein levels.
FIG. 4. SEL-10 binds to phosphorylated Notch. Notch4(int-3)
NTHA and SEL-10myc were coexpressed in Bosc23 cells by transient
transfection. Immunoprecipitation (IP) was performed with either an-
ti-HA or anti-myc antibody. Each precipitate was divided into two
tubes; one was treated with CIP, and one was left untreated. The blot
was probed with anti-HA antibody to visualize Notch4(int-3)NTHA
precipitated either directly by anti-HA antibody or indirectly by anti-
myc antibody. Arrows indicate the three species of Notch4(int-3)
NTHA. Stars indicate the heavy and light chains of immunoglobulin.
FIG. 3. The C-terminal domain of Notch4 mediates the interaction of Notch4 and SEL-10. (A) Epitope-tagged Notch4(int-3) deletion variants.
The HA tag is labeled in yellow, and six-His tags are labeled in red. (B) Physical interactions between SEL-10 and Notch4 deletion variants.
Six-myc-epitope-tagged full-length hSEL-10 was coexpressed with HA-tagged Notch4(int-3) deletion variants in Bosc23 cells. All the proteins were
well expressed (second panel from the top and bottom panel), except for NTCTHA (bottom panel, lanes 5 and 11). Anti-HA antibody was used
to detect Notch4 proteins in the immunoprecipiates of SEL-10myc (top panel), and anti-myc antibody was used to detect SEL-10myc in the
immunoprecipitates of Notch4 proteins (third panel from the top). (C) A C-terminal fragment of Notch4 complexes with SEL-10 in the presence
of a proteasome inhibitor. Notch4(int-3)CHAHis, a fragment of Notch4 containing only the C-terminal domain, was tested for its ability to
coimmunoprecipitate with SEL-10. Before the coimmunoprecipitation assays, cells were either treated with lactacystin, a specific proteasome
inhibitor, or left untreated. The bottom two panels show that both Notch4(int-3)C and SEL-10 are well expressed. Notch4(int-3)C can be detected
by anti-HA antibody in the immune complex of SEL-10myc (top panel). Arrows in the top two panels indicate the signal of Notch4(int-3)CHAHis,
and the arrow in the bottom panel indicates the major species of SEL-10myc protein. IP, immunoprecipitation.
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Figure 5C shows that in the absence of lactacystin, more than
half of the N4(int-3)C protein was turned over after approxi-
mately 1.5 h of chase. In contrast, after treatment with 10 M
lactacystin, the amount of Notch4(int-3)C was diminished only
slightly throughout the 2.5-h chase. Based on these results, the
increase in Notch4(int-3)C levels after lactacystin treatment
(Fig. 5A) was likely due to decreased degradation by the pro-
teasome pathway.
To determine whether endogenous SEL-10 was required to
target Notch proteins for turnover, we used the dominant-
negative form of SEL-10, which interferes with endogenous
SEL-10 function (SEL-10WDmyc; Fig. 1B). We tested the
ability of SEL-10WDmyc, which expresses only the WD40 re-
peats and not the F-box, to interfere with endogenous SEL-10
function by coexpressing SEL-10WDmyc with either
Notch4(int-3)C or N1ICHA in Bosc23 cells. Two days after
transfection, cells were harvested and the steady-state levels of
Notch proteins were examined by Western blot analysis. The
expression of SEL-10WDmyc resulted in increased steady-
state levels of N4(int-3)C (Fig. 6A) and of Notch1IC (Fig. 6B).
The increased levels of these proteins were apparent after
equivalent levels of the plasmids were used in transfection, and
the levels increased in a dosage-dependent manner as more
SEL-10WDmyc plasmid was used. The increased expression of
N4(int-3)C upon coexpression of SEL-10WDmyc was reflected
in increased stability of the protein after pulse-chase analysis
and quantitation (Fig. 6C). In contrast, the expression of full-
length SEL-10 did not have a significant effect on steady-state
levels of Notch1IC (data not shown). Thus, the WD40 repeat
region of SEL-10 functions as a dominant-negative form of
SEL-10, and the expression of this form results in decreased
turnover of Notch proteins. In contrast, expression of the SEL-
10WDmyc plasmid did not significantly alter the levels of
oncogenic Notch4(int-3) protein (data not shown). This result
is consistent with the lack of an appreciable increase in signal-
ing mediated by Notch4(int-3) when coexpressed with SEL-
10WDmyc (data not shown).
SEL-10 mediates Notch protein ubiquitination in vitro. To
examine whether SEL-10 functions as part of an SCF ubiquitin
ligase that can target Notch proteins for ubiquitin-dependent
degradation, we first tested whether SEL-10myc and SEL-
10WDmyc assembled into SCF complexes. Both proteins were
FIG. 5. Notch proteins are stabilized by proteasome inhibitor treatment. (A) Two micrograms of a plasmid expressing Notch4(int-3)CHAHis
was transiently transfected into Bosc23 cells on a 60-mm plate. The cells were treated with 10 M lactacystin for the indicated number of hours
before harvest. Western blotting using anti-HA antibody was carried out to assess the steady-state levels of expression of Notch4(int-3)CHAHis
(arrow). (B) A Notch1 fragment containing the intracellular domain tagged with HA and hexahistidine was expressed in Bosc23 cells by transient
transfection. Cells were treated with a proteasome inhibitor, MG132, for 12 h before harvest. Dimethyl sulfoxide (DMSO) was used as a negative
control. The arrow indicates the Notch1 protein revealed by Western blotting using anti-HA antibody. (C) Proteasome inhibitor treatment leads
to a longer half-life for the Notch protein. Bosc23 cells were transfected to express Notch4(int-3)CHAHis. Two days after transfection, cells were
pulse-labeled with 35S-labeled methionine and cysteine for 30 min and chased with regular DMEM for up to 2.5 h. Samples were harvested every
0.5 h and then immunoprecipitated using anti-HA antibody. The immunoprecipitates were separated by SDS-PAGE and autoradiographed to
reveal the amount of labeled Notch4(int-3)CHAHis. For cells treated with 10 M lactacystin, a proteasome inhibitor was added to both
pulse-labeling and pulse-chase media. Arrows indicate the two bands representing Notch4(int-3)CHAHis.
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coexpressed in insect cells with hCUL1, hSKP1, and hHRT1,
all components of the SCF complex. SEL-10 protein com-
plexes were retrieved by immunoprecipitation with anti-myc
antibody beads. Full-length SEL-10 efficiently coprecipitated
hCUL1, hSKP1, and hHRT1, but the WD40 repeat domain by
itself was unable to recruit the other SCF subunits (Fig. 7A);
these results provide an explanation for the observed domi-
nant-negative effect of SEL-10WDmyc in transfected cells
(Fig. 1C and E and Fig. 6).
We next tested whether Notch proteins were ubiquitinated
by recombinant SCFSEL-10. As shown in Fig. 7B, high-molec-
ular-weight (HMW) forms of coprecipitated Notch4(int-3),
Notch4(int-3)CHAHis, and N1ICHAHis proteins were gener-
ated in the presence of SEL-10myc immunoprecipitates that
contained all subunits of SCF but not in the presence of SEL-
10WDmyc immunoprecipitates. Formation of the HMW forms
of Notch4 proteins was dependent on the presence of ubiq-
uitin, confirming that Notch4 was ubiquitinated in the presence
of SCFSEL-10. We next examined in more detail N1ICHAhis
ubiquitination in the presence or absence of ubiquitin and its
chain-terminating derivative, methyl-ubiquitin. In the presence
of ubiquitin and SCFSEL-10, SCF-bound N1ICHAHis was com-
pletely converted into HMW conjugates. These conjugates mi-
grated as an apparent band instead of as a more characteristic
smear, because they were compressed at the interface of the
stacking and running gels. Substituting ubiquitin with methyl-
FIG. 6. Expression of the WD40 repeats of SEL-10 stabilizes Notch proteins. (A) Plasmids expressing Notch4(int-3)CHAHis and SEL-
10WDmyc were cotransfected into Bosc23 cells. The amounts of plasmids used are indicated at the top of the panel. Two days after transfection,
cells were harvested and subjected to Western blotting. The steady-state levels of the HA-tagged Notch protein are indicated by the arrows. (B)
SEL-10WDmyc was coexpressed with N1ICHAHis, a Notch1 fragment containing the intracellular domain. Two days later, the steady-state levels
of expression of N1ICHAHis (arrow) were assessed by Western blotting. (C) Overexpression of the WD40 repeats of SEL-10 results in an
increased half-life for Notch4(int-3)CHAHis. A pulse-chase labeling experiment was done in the absence or presence of SEL-10WDmyc to
determine the half-life of Notch4(int-3)CHAHis. Metabolically labeled Notch4(int-3)CHAHis (arrows) was visualized by immunoprecipitation
followed by autoradiography.
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FIG. 7. SCFSEL-10 mediates Notch ubiquitination in vitro. (A) Full-length SEL-10 but not the WD40 repeat domain interacts with other SCF
components. Hi5 insect cells were coinfected with a cocktail of recombinant baculoviruses that expressed hCUL1, hSKP1, and hHRT1 plus either
full-length SEL-10myc or SEL-10WDmyc. Crude lysates and anti-myc immunoprecipitates prepared from infected cells were fractionated by
SDS-PAGE and evaluated by Western blotting with anti-myc, anti-CUL1, anti-SKP1, and anti-HRT1 antibodies. (B) SCFSEL-10 mediates
ubiquitination of Notch proteins in vitro. Bead-bound SCF complexes, prepared as described for panel A, were incubated with crude lysates of Hi5
insect cells infected with recombinant baculoviruses that expressed Notch4(int-3)HA, Notch4(int-3)CHAHis6, and N1ICHAHis6 to allow sub-
strate binding. Beads were washed three times with lysis buffer and incubated with six-His-tagged yeast UBA1, hCDC34, and ATP-regenerating
system (Rxn). Ubiquitin (Ub) was either included in or omitted from the reactions. Following incubation for 60 min at 30°C, the samples were
fractionated by SDS-PAGE, and Notch4 proteins were visualized by Western blotting with anti-HA antibody. Arrows designate extensively
ubiquitinated forms of Notch proteins. (C) N1ICHAHis6 ubiquitination by SCFSEL-1 and SCFSEL-10WDmyc. Ubiquitination reactions were per-
formed as described for panel B, except that methylubiquitin (Me Ub) was used where indicated to inhibit multiubiquitin chain formation. Arrows
designate multiubiquitinated forms of Notch proteins. IP, immunoprecipitation.
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ubiquitin dramatically reduced the apparent size of ubiquiti-
nated N1ICHAHis, whereas the omission of ubiquitin from the
reaction completely abolished the formation of HMW conju-
gates. These results confirm that the HMW forms observed
were ubiquitinated forms of N1ICHAHis. As expected, immu-
noprecipitates that contained full-length SEL-10 but not those
that contained SEL-10WD retained N1ICHAHis ubiquitina-
tion in vitro.
DISCUSSION
Although the mechanisms of Notch/LIN-12 signal transmis-
sion are being defined through genetic and biochemical anal-
yses, little is known about the mechanisms involved in down-
regulating the Notch signal. Notch signaling mediates
numerous key developmental decisions in both vertebrates and
invertebrates. As such, mechanisms to down-regulate Notch
signaling are likely critical to maintain proper developmental
programs or to prevent oncogenic functions of Notch proteins.
sel-10 was originally identified genetically in C. elegans as a
negative regulator of lin-12 activity (10). The fact that the
SEL-10 protein is related to the F-box/WD40 repeat family of
proteins suggested that SEL-10 down-regulates Notch/LIN-12
signaling by targeting these proteins for ubiquitin-mediated
protein turnover (10). This proposed function of SEL-10 would
represent a key mechanism by which Notch signaling is re-
duced in physiological settings. Based on the paradigm estab-
lished by analysis of budding yeast Cdc4, F-box/WD40 proteins
are predicted to bind their target proteins in a phosphoryla-
tion-dependent fashion.
Here, we demonstrate that Notch1 signaling is negatively
regulated by SEL-10. Interference with SEL-10 function by
expression of the WD repeat region enhances steady-state
levels of Notch1 proteins by reducing the rate of turnover, thus
increasing Notch1-mediated signaling, indicating that SEL-10
is directly involved in mediating Notch ubiquitination and deg-
radation. We also found the Notch4 proteins interact efficiently
with SEL-10 but that the levels and activity of the intracellular
domain of Notch4, Notch4(int-3), are relatively resilient to
interference with SEL-10 function. Thus, these two Notch pro-
teins behave differently in response to blocking of SEL-10
function.
The ease with which we could detect Notch4(int-3)–SEL-10
protein complexes prompted us to choose Notch4(int-3) pro-
teins as a focus for detailed binding studies. This proved an
effective way of dissecting the biochemical interactions in
greater detail than could be achieved with substrates that
would be tremendously labile when complexed to SEL-10. We
demonstrated that the WD40 repeats of SEL-10 bind to the
C-terminal domain of Notch4, a domain important for Notch4
phosphorylation. Moreover, SEL-10 binds preferentially to
phosphorylated forms of Notch4 and shields the phosphate
groups from nonspecific dephosphorylation by CIP, suggesting
that the interaction is directly mediated by phosphorylated
amino acids within the C-terminal domain of Notch4. We also
found that several forms of Notch proteins, Notch1ICD and
Notch4(int-3)C, are very unstable as a result of rapid turnover
via the proteasome pathway. However, full-length SEL-10 ex-
pression did not have an appreciable effect on Notch protein
levels or activities (data not shown). This result may indicate
that sufficient SEL-10 activity exists in these cells to mediate
Notch protein turnover.
Finally, recombinant SEL-10 assembles into SCF ubiquitin
ligase complexes in insect cells. These complexes bind coex-
pressed Notch and mediate highly processive (and efficient)
ubiquitination of bound Notch proteins. Given that other SCF
complexes (including SCFCdc4, SCFGrr1, SCFSkp2, and SCF-
TRCP) have been shown to be extremely selective for phosphor-
ylated substrates, we presume that recombinant Notch proteins
are targeted to SCFSEL-10 by an endogenous protein kinase in
insect cells. Although the exact mechanism by which Notch
proteins are targeted for ubiquitination remains unclear, it is
evident from the in vitro experiments that Notch proteins can
serve as excellent substrates for SCFSEL-10. Given the extraor-
dinary substrate specificity that is evinced by all other SCF
ubiquitin ligases that have been evaluated to date, the efficient
and highly processive in vitro ubiquitination that we observed
(Fig. 6C) indicates that Notch is a physiological substrate for
SCFSEL-10. Based on all of the data, the most parsimonious
hypothesis is that the phosphorylation of Notch by an uniden-
tified protein kinase targets it to SCFSEL-10, which in turn
extensively ubiquitinates Notch as a prelude to its degradation.
Conclusive proof of this hypothesis in vivo will ultimately re-
quire the mapping of phosphorylation sites and the construc-
tion of nonphosphorylatable point mutant versions of Notch.
We conclude that the C-terminal domain of Notch4 distal to
the CDC10/ankyrin repeats is a negative regulatory domain
because it is responsible for interactions with SEL-10. This
notion is consistent with the fact that the C-terminal domain
contains a PEST sequence, which is characteristic of many
short-lived proteins and which is thought to be a target for
phosphorylation and ubiquitination (28). It has also been ob-
served that a C-terminal deletion can activate GLP-1, a C.
elegans Notch protein (22). The C-terminal domain of Notch
proteins is also where some other regulatory proteins bind. For
example, Drosophila protein Dishevelled has been reported to
bind to this region and may thus mediate the interaction be-
tween the Wingless and Notch signaling pathways (2). Our
results predict that Notch levels and activity may be controlled
by a kinase(s) that phosphorylates the C terminus of Notch
proteins. This phosphorylation would mediate SEL-10 binding
and thus ubiquitination and degradation by the 26S protea-
some. Little is known about kinases that phosphorylate and
regulate Notch, but one would predict that the kinase that
phosphorylates the C terminus has a negative regulatory func-
tion in Notch signaling.
An interesting observation is that Notch4(int-3) proteins
show strong and specific interactions with SEL-10 but do not
seem to be readily degraded by the proteasome pathway, in
contrast to Notch1IC. Overexpression of the WD40 repeat
region or treatment by lactacystin failed to increase the steady-
state levels of Notch4(int-3) (data not shown). Pulse-chase
analysis indicated that Notch4(int-3) has a much longer half-
life in cells than does Notch4(int-3)C, the C-terminal domain
of Notch4(int-3) (data not shown). However, Notch4(int-3)
still seems to be ubiquitinated in cells because a Western blot
of Notch4(int-3) often displays a very high-molecular-weight
smear in addition to the main Notch4(int-3) signal at the pre-
dicted molecular weight (unpublished observations). This
smear can be seen even without proteasome inhibitor treat-
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ment and is very typical of proteins that are ubiquitinated.
Notch4(int-3) also serves as a substrate for SEL-10-dependent
in vitro ubiquitination (Fig. 7A). The fact that Notch4(int-3)
protein levels are relatively unaffected by interference with
SEL-10 activity is consistent with the fact that in signaling
assays, Notch4(int-3) activity was not elevated by coexpres-
sion with a dominant-negative form of SEL-10 (data not
shown). One possible explanation for these observations is
that the extracellular sequence, the transmembrane domain,
or the ankyrin repeats in Notch4(int-3) can function to pre-
vent the protein from being degraded by the proteasome
even after ubiquitination. The resultant increased stability
of Notch4(int-3) may also contribute to the potent oncogenic
activity of this variant of Notch4, whose gene was originally
defined as a mammary oncogene (12, 29). In contrast, our
studies show that Notch4(int-3)C and Notch1IC, both lacking
a transmembrane domain and extracellular sequence, can be
readily stabilized by proteasome inhibitors or overexpression
of the WD40 repeat region of SEL-10. This issue can be fur-
ther addressed by biochemical studies using a Notch4(int-3)
fragment containing only the intracellular domain or possibly
chimeric proteins of Notch4(int-3) and Notch1IC.
Other reports also suggest that Notch proteins are likely
turned over by ubiquitination. For example, it has been re-
ported that the steady-state level of the Notch1 intracellular
domain can be elevated by lactacystin, a proteasome inhibitor
(32). In addition, Notchless, a novel Drosophila gene identified
as a modulator of Notch activity, encodes a WD40 repeat-
containing protein that binds to the intracellular domain of
Notch (31). However, the function of Notchless is not clear
because both loss-of-function mutations and overexpression of
the gene lead to increased Notch activity. These results, once
again, suggest that regulation of the Notch pathway is very
complex. A recent report suggests that Notch proteins are
targets for ubiquitination and provides biochemical evidence
that the Itch protein may participate in mediating Notch ubiq-
uitination (27). However, this study did not establish that Itch
is responsible for or participates in the ubiquitination of Notch
in vivo or that Notch ubiquitination, stability, or activity is
altered in mice with the Itch mutation.
Ubiquitin-mediated protein degradation is a highly regu-
lated and selective process used to down-regulate several sig-
naling pathways (1, 3). F-box/WD40 family proteins can bind
to multiple target proteins (23, 44, 46). We report that Notch
signaling also utilizes ubiquitin-mediated protein turnover to
down-regulate the Notch/LIN-12 signal. This is evident both in
C. elegans (10) and in Notch signaling in mammalian cells (Fig.
1C and D). Thus, clear evidence from sequence homology,
functional studies, and binding studies points to the high level
of conserved function of SEL-10 as a negative regulator of
Notch signaling from worms to humans. SEL-10 also interacts
genetically and physically with the C. elegans presenilin,
SEL-12 (45), and may target both Notch and presenilin for
degradation. The data presented here suggest that hSEL-10
may serve a similar role in the down-regulation of presenilin
function as in the down-regulation of Notch. Presenilin is re-
quired for the activation of Notch, probably by mediating the
proteolytic cleavage of the transmembrane domain of Notch,
enabling the nuclear access of the Notch intracellular domain
(5, 35, 47). It is not clear whether SEL-10 has effects on the
presenilin-Notch interaction or whether it targets each protein
separately. It will be interesting to define how SEL-10 is di-
rected to distinct targets, such as Notch and presenilins. Un-
derstanding how Notch proteins are regulated by SEL-10 may
also provide new approaches to controlling Notch activity. For
example, as constitutive activation of Notch can lead to tumor-
igenesis, SEL-10 activity could be used to reverse Notch activ-
ity in these circumstances.
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